Good, bad news for Chemical Financing (Y&P article in ICIS Chemical Business) Nov 2 – Nov 8, 2018 issuenews2021-07-01T19:07:25+00:00November 2nd, 2018|Our Publications|
Business Check – Industry Financial Pulse (Young & Partners article in Pharm Exec Nov 2018)news2021-07-01T19:07:30+00:00November 1st, 2018|Our Publications|
Chemical M&A – Reality vs Myth (Y&P article in ICIS Chemical Business) Oct 26 – Nov 1, 2018 issuenews2021-07-01T19:10:05+00:00October 26th, 2018|Our Publications|
The Rise of China Biopharma (Pharmaceutical Executive – July issue)news2021-07-01T19:10:00+00:00July 1st, 2018|Our Publications|
Dr. Spielberg, former Deputy Commissioner of the FDA, joins Young & Partners (June 11, 2018)news2021-07-01T19:09:54+00:00June 11th, 2018|Our Publications|
Banker: Value of Closed M&A Soars in 2017 due to Mega Deals (Feb 12 – 19, 2018, Chemical Week)news2021-07-01T19:09:48+00:00February 12th, 2018|Our Publications|
Stock Market and Financing – Strong with a Twist (ICIS Chemical Business, Feb 2, 2018 issue)news2021-07-01T19:09:42+00:00February 2nd, 2018|Our Publications|
Pharma and Biotech: Strategic, M&A and Financial Yearend Review and Outlook (Pharma Exec Feb 2018 issue)news2021-07-01T19:09:36+00:00February 1st, 2018|Our Publications|
Chemical M&A – Below the Surface (ICIS Chemical Business, Jan 26, 2018 issue)news2021-07-01T19:09:30+00:00January 26th, 2018|Our Publications|
Chemical M&A and IPOs – A Warped View – Young & Partners (ICIS Chemical Business Nov. 10 – 16, 2017 issue)news2021-07-01T19:09:25+00:00November 10th, 2017|Our Publications|
